BioSpace News Archive

Pharm Country

Kamada Provides Corporate Update on its Israel Operations

Kamada Ltd. today announced that while circumstances in Israel are evolving, the Company continues to conduct its business operations in Israel with no effect on business continuity, and its global supply of products is not expected to be interrupted.

October 10, 2023
·
4 min read
Genetown

Cerevance to Participate at the 3rd Annual Needham Biotech Private Company Forum

Cerevance today announced participation at the upcoming 3rd Annual Needham Biotech Private Company Forum, taking place virtually from October 17 – 18, 2023.

October 10, 2023
·
2 min read
Business

Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors

Renovaro Biosciences Inc. is pleased to announce the appointment of Leni Boeren and Ruud Hendriks as Independent Directors.

October 10, 2023
·
9 min read
Biotech Bay

Acurex Biosciences to Present at the Michael J. Fox Foundation Parkinson’s Disease Therapeutics Conference

Acurex Biosciences Corporation has been selected to present at the 15th annual Parkinson’s Disease Therapeutics Conference hosted by the Michael J. Fox Foundation.

October 10, 2023
·
2 min read
AstriVax Strengthens Leadership Team by Welcoming Chief Development Officer (CDO) Dr. Mathieu Peeters and Chief Financial Officer (CFO) Barbara Freitag

AstriVax is pleased to announce that Dr. Mathieu Peeters and Barbara Freitag have joined the company’s leadership team as Chief Development Officer and Chief Financial Officer, respectively.

October 10, 2023
·
2 min read
Drug Development

Transgene and BioInvent - First Patient Treated in Part B of Phase I Trial Assessing the Novel Oncolytic Virus BT-001 in Combination With KEYTRUDA® (pembrolizumab)

Transgene and BioInvent International AB announce that the first patient of the Phase I part B clinical trial evaluating the combination of BT-001 and MSD’s anti-PD-1 therapy, KEYTRUDA® has been dosed.

October 10, 2023
·
7 min read
Drug Development

BioInvent and Transgene: First patient treated in Part B of Phase 1 trial assessing the novel oncolytic virus BT-001 in combination with KEYTRUDA® (pembrolizumab)

BioInvent International AB and Transgene announce that that the first patient of the Phase 1 part B clinical trial evaluating the combination of BT-001 and MSD’s anti-PD-1 therapy, KEYTRUDA® has been dosed.

October 10, 2023
·
8 min read
Biotech Bay

Bayer Opens First Cell Therapy Manufacturing Facility to Advance Regenerative Medicines on a Global Scale

Bayer AG announced the opening of its first Cell Therapy Launch Facility in Berkeley, California to create the capacity to bring cell therapies to patients on a global scale.

October 10, 2023
·
8 min read
Berlin Cures takes next step in battle against Long COVID

Berlin Cures, a biotechnology firm specializing in the neutralization of functional autoantibodies, is extending its collaboration with Uniklinikum Erlangen in the fight against Long COVID.

October 10, 2023
·
3 min read
CanariaBio and Hikma announce the signing of distribution and license agreement for oregovomab in MENA Region

CanariaBio Inc. and Hikma MENA FZE, part of Hikma Pharmaceuticals PLC, announced the signing of distribution and license agreement for oregovomab in the Middle East and North Africa region.

October 10, 2023
·
2 min read